SCHEMBL2548129

SCHEMBL2548129

COc1cccc(OC)c1-c1cccc(I)c1P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.37
DRD2 P14416 3/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RPS6KA2 Q15349 1/20 0.35
TOP1 P11387 1/20 0.35
HTR7 P34969 2/20 0.35
ABCB1 P08183 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HPGD P15428 2/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
POLL Q9UGP5 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21331833 0.90 HTR1A (0.41) HTR1ADRD2MEN1KMT2ARPS6KA2
SCHEMBL15056054 0.86 CA1 (0.36) HTR1ACA1CA2CA7CA9
SCHEMBL26556073 0.84 HTR1A (0.37) HTR1ADRD2MEN1KMT2ARPS6KA2
SCHEMBL30751957 0.84 HTR1A (0.40) HTR1ADRD2MEN1KMT2ARPS6KA2
SCHEMBL29375643 0.84 HTR1A (0.37) HTR1ADRD2MEN1KMT2ARPS6KA2
SCHEMBL31669654 0.83 HTR1A (0.36) HTR1ADRD2MEN1KMT2ARPS6KA2
SCHEMBL31175024 0.80 MEN1 (0.38) HTR1ADRD2MEN1KMT2ATOP1
SCHEMBL8960493 0.80 ABCB1 (0.35) RPS6KA2ABCB1SMN1; SMN2HPGDPOLL
SCHEMBL1102294 0.79 ABCB1 (0.43) DRD2ABCB1SMN1; SMN2HPGDCA1
SCHEMBL21331896 0.79 DRD2 (0.38) HTR1ADRD2MEN1KMT2ARPS6KA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3245206-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. Hoffmann-La Roche AG (CH) 2017-11-22 EP disclosed
WO-2016113273-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2016-07-21 WO disclosed
EP-2635565-A1 5 -CYANO-4, 6 -DIAMINOPYRIMIDINE OR 6 -AMINOPURINE DERIVATIVES AS PI3K- DELTA INHIBITORS Amgen Inc. (US) 2013-09-11 EP disclosed
EP-2552908-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2013-02-06 EP disclosed
WO-2012061696-A1 5 -CYANO-4, 6 -DIAMINOPYRIMIDINE OR 6 -AMINOPURINE DERIVATIVES AS PI3K- DELTA INHIBITORS AMGEN INC. (US) 2012-05-10 WO disclosed
WO-2011123751-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2011-10-06 WO disclosed